Loading...

PE/Cyanine7 anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_PECy7_042706
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
  • M1slash70_PECy7_042706
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) PE/Cyanine7 (filled histogram) or rat IgG2b, κ PE/Cyanine7 isotype control (open histogram) (gated on total cells).
Compare all formats See PE/Cyanine7 spectral data
Cat # Size Price Quantity Check Availability Save
101215 25 µg 70€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
101216 100 µg 169€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Wang L, et al. 2021. J Nanobiotechnology. 19:56. PubMed
  2. Kuo PC, et al. 2021. Brain Commun. 3:fcab187. PubMed
  3. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  4. Cheresh P, et al. 2021. Int J Mol Sci. 22:. PubMed
  5. Deng R, et al. 2022. Adv Sci (Weinh). 9:e2103343. PubMed
  6. Odom CV, et al. 2021. J Immunol. 207:1891. PubMed
  7. Parsons M, et al. 2014. J Immunol. 192:1361. PubMed
  8. Tebartz C, et al. 2015. J Immunol. 194:1100. PubMed
  9. Quispe Calla N, et al. 2016. Sci Rep. 6:37723. PubMed
  10. D'Alessandro G, et al. 2020. Eur J Immunol. 50:705. PubMed
  11. DeSouza-Vieira T, et al. 2020. Cell Rep. 33:108317. PubMed
  12. Gogoi H, et al. 2020. Front Immunol. 1.620833333. PubMed
  13. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  14. Hatzi K, et al. 2019. Nat Immunol. 20:86. PubMed
  15. Tran NT, et al. 2019. Cell Rep. 28:3510. PubMed
  16. Lin C et al. 2019. Immunity. 50(1):137-151 . PubMed
  17. Okunuki Y, et al. 2018. Proc Natl Acad Sci U S A. 115:E6264. PubMed
  18. Yu X, et al. 2020. Nat Commun. 11:1110. PubMed
  19. Kitagawa S, et al. 2022. NPJ Vaccines. 7:115. PubMed
  20. Rodrigues M, et al. 2022. Biochem J. 479:1891. PubMed
  21. Jung MY, et al. 2022. Neurooncol Adv. 4:vdac017. PubMed
  22. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  23. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  24. Sharma GP, et al. 2021. PLoS One. 16:e0259042. PubMed
  25. Li Z, et al. 2021. Immunology. 163:105. PubMed
  26. Correa S, et al. 2020. ACS Nano. 14:2224. PubMed
  27. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  28. Gazit R, et al. 2014. J Exp Med. 211:1315. PubMed
  29. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  30. Thelin MA, et al. 2017. Diabetes. 66:2220. PubMed
  31. Zhang LJ, et al. 2019. Immunity. 50:121. PubMed
  32. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  33. Frisbee AL, et al. 2019. Nat Commun. 10:2712. PubMed
  34. Groza D, et al. 2018. Oncoimmunology. 7:e1424676. PubMed
  35. Alissafi T, et al. 2018. J Clin Invest. 128:3840. PubMed
  36. Iwamoto H et al. 2018. Cell metabolism. 28(1):104-117 . PubMed
  37. McGill BE et al. 2018. The Journal of Neuroscience. 38(1):200-219 . PubMed
  38. Wei H, et al. 2021. Malar J. 20:89. PubMed
  39. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 5:64. PubMed
  40. Hickey A, et al. 2021. Front Microbiol. 12:653587. PubMed
  41. Morgan PK, et al. 2021. J Biol Chem. 297:101341. PubMed
  42. Yang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  43. Piepke M, et al. 2021. J Neuroinflammation. 18:265. PubMed
  44. Jiang W, et al. 2021. Oncol Lett. 22:625. PubMed
  45. Chen T, et al. 2021. JCI Insight. 6:. PubMed
  46. Radovanovic I, et al. 2014. J Immunol. 193:1290. PubMed
  47. Zasłona Z, et al. 2014. J Immunol. 193:4245. PubMed
  48. Zheng W, et al. 2021. Wellcome Open Research. 6:52. PubMed
  49. Mogilenko DA, et al. 2020. Immunity. 54(1):99-115.e12. PubMed
  50. Riether C, et al. 2021. Cell Reports. 34(4):108663. PubMed
  51. Yu K, et al. 2021. Cell Reports. 35(12):109273. PubMed
  52. Kurelac I, et al. 2019. Nat Commun. 10:903. PubMed
  53. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  54. Delás MJ, et al. 2019. Cell Rep. 27:719. PubMed
  55. Yang X, et al. 2020. Blood Sci. 2:89. PubMed
  56. Deslyper G, et al. 2021. Parasitology. 148:539. PubMed
  57. Shen H, et al. 2015. Infect Immun . 83: 2694 - 2704. PubMed
  58. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  59. Saggu G, et al. 2018. Nat Commun. 9:5058. PubMed
  60. Yuzhu Hou et al. 2018. Immunity. 49(3):490-503 . PubMed
  61. Bowers E, et al. 2018. Nat Med. 24:95. PubMed
  62. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  63. Park JA, et al. 2021. J Hematol Oncol. 14:142. PubMed
  64. Zong L, et al. 2021. NPJ Aging Mech Dis. 7:25. PubMed
  65. Almutairi F, et al. 2021. Front Immunol. 12:772288. PubMed
  66. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  67. Royzman D, et al. 2022. Front Immunol. 13:1012647. PubMed
  68. Martin R, et al. 2014. J Leukoc Biol. 96:151. PubMed
  69. Shemer A, et al. 2020. Immunity. 53(5):1033-1049.e7. PubMed
  70. Yamamoto K, et al. 2021. Cell Reports. 36(8):109576. PubMed
  71. Uroda T, et al. 2020. Nat Protoc. 15:2107. PubMed
  72. Akhmetzyanova ER, et al. 2019. Front Cell Neurosci. 12:507. PubMed
  73. Lubkin A et al. 2019. Cell host & microbe. 25(3):463-470 . PubMed
  74. Gibson EM, et al. 2019. Cell. 176:43:00. PubMed
  75. Juttukonda LJ, et al. 2017. Cell Host Microbe. 22:531. PubMed
  76. LaFleur MW, et al. 2019. Nat Immunol. 20:1335. PubMed
  77. Somerville TD, et al. 2020. eLife. 9:e53381.. PubMed
  78. Xu X, et al. 2021. J Nanobiotechnology. 19:376. PubMed
  79. Walker FC, et al. 2021. PLoS Pathog. 17:e1009402. PubMed
  80. Johansen AZ, et al. 2022. Pharmaceutics. 14:. PubMed
  81. Liu Y, et al. 2022. Nat Commun. 13:2665. PubMed
  82. Beauchamp EM, et al. 2021. Blood Cancer Discov. 6:. PubMed
  83. Dodagatta-Marri E, et al. 2021. Cell Rep. 36:109309. PubMed
  84. Super M, et al. 2021. Nat Biomed Eng. Online ahead of print. PubMed
  85. Kulkarni NN, et al. 2021. J Biol Chem. 297:100828. PubMed
  86. Jia X, et al. 2021. Front Cell Dev Biol. 9:685522. PubMed
  87. Klopfenstein N, et al. 2021. PLoS Pathog. 17:e1009387. PubMed
  88. Ellis G, et al. 2015. EMBO Rep. 16: 1203-1218. PubMed
  89. Vazquez S, et al. 2015. Exp Hematol. 43: 578-585. PubMed
  90. Shade K, et al. 2015. J Exp Med. 212:457. PubMed
  91. Sasaki K, et al. 2019. Nat Commun. 10:3878. PubMed
  92. Angelidis I, et al. 2019. Nat Commun. 10:963. PubMed
  93. Hore ZL, et al. 2021. Wellcome Open Res. 6:68. PubMed
  94. Wang L, et al. 2021. Cancer Immunol Res. 9:348. PubMed
  95. Enriquez AB, et al. 2022. iScience. 25:104305. PubMed
  96. Shin JE, et al. 2021. Heliyon. 7:e08433. PubMed
  97. Koh F, et al. 2015. Proc Natl Acad Sci U S A. 112:1734. PubMed
  98. Kohn M, et al. 2021. Front Immunol. 580594:12. PubMed
  99. Liang Z, et al. 2020. Pain. 161:2089. PubMed
  100. Vasilijevic J, et al. 2017. PLoS Pathog. 13:e1006650. PubMed
  101. Meeks K, et al. 2009. J Immunol. 183:8026. PubMed
  102. Amo-Aparicio J, et al. 2021. Theranostics. 11:9805. PubMed
  103. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  104. Goldman E, et al. 2021. Cells. 10:. PubMed
  105. Dokoshi T, et al. 2021. J Clin Invest. 131:. PubMed
  106. Pan YC, et al. 2021. Mol Ther Oncolytics. 20:175. PubMed
  107. Aegerter H, et al. 2020. Nat Immunol. 0.975694444. PubMed
  108. Zhang S, et al. 2020. Front Immunol. 1.757638889. PubMed
  109. Kirschbaum K, et al. 2016. Proc Natl Acad Sci U S A. 113: 13227 - 13232. PubMed
  110. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  111. Snell LM, et al. 2018. Immunity. 49:678. PubMed
  112. Huang YL, et al. 2021. Commun Biol. 4:229. PubMed
  113. Littwitz-Salomon E, et al. 2021. Nat Commun. 12:5376. PubMed
  114. Synn CB, et al. 2022. Clin Transl Immunology. 11:e1364. PubMed
  115. Xie Z, et al. 2020. Light Sci Appl. 0.486805556. PubMed
  116. Gomzikova MO, et al. 2020. Sci Rep. 10:10740. PubMed
  117. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  118. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  119. Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
  120. Kooreman NG et al. 2018. Cell stem cell. 22(4):501-513 . PubMed
  121. Proto JD et al. 2018. Immunity. 49(4):666-677 . PubMed
  122. Secondini C, et al. 2017. Oncoimmunology. 6:e1316437. PubMed
  123. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  124. Uddin MJ, et al. 2022. Mucosal Immunol. 15:165. PubMed
  125. Wang D, et al. 2021. Nat Commun. 12:2674. PubMed
  126. Jia Q, et al. 2021. Theranostics. 4699:11. PubMed
  127. Dobosz E, et al. 2021. Dis Model Mech. :14. PubMed
  128. Mulas F, et al. 2020. Cell Mol Immunol. . PubMed
  129. Zhu H, et al. 2021. Cell Metabolism. :. PubMed
  130. Bambouskova M, et al. 2021. Cell Reports. 34(10):108756. PubMed
  131. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  132. Pérez-Girón J, et al. 2015. J Vis Exp. 100: 52803. PubMed
  133. Suresh MV, et al. 2019. JCI Insight. 4:e133103. PubMed
  134. Patel S, et al. 2019. Viruses. 0.877083333. PubMed
  135. Bradley KC, et al. 2019. Cell Rep. 28:245. PubMed
  136. Kumar MP, et al. 2018. Cell Rep. 25:1458. PubMed
  137. Steuerman Y et al. 2018. Cell systems. 6(6):679-691 . PubMed
  138. Li H, et al. 2020. Nature. 584:274. PubMed
  139. Sibilio A, et al. 2022. iScience. 25:103790. PubMed
  140. Dey S, et al. 2020. J Immunother Cancer. 8:. PubMed
  141. Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
  142. Liu H, et al. 2022. Front Pharmacol. 13:949316. PubMed
  143. Boulay A, et al. 2015. J Neurosci. 35:4427. PubMed
  144. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  145. Lim CX, et al. 2020. Cell Rep. 3793:30. PubMed
  146. Li Z, et al. 2018. Front Immunol. 9:347. PubMed
  147. Marcus A et al. 2018. Immunity. 49(4):754-763 . PubMed
  148. Van Winkle JA et al. 2018. Cell host & microbe. 24(5):665-676 . PubMed
  149. LaFleur MW, et al. 2019. Nat Commun. 10:1668. PubMed
  150. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  151. Tran NT, et al. 2020. STAR Protocols. 1(1):100028. PubMed
  152. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  153. Monaghan KL, et al. 2020. J Vis Exp. . PubMed
  154. Frenis K, et al. 2021. Basic Res Cardiol. 31:116. PubMed
  155. Crouse B, et al. 2020. NPJ Vaccines. 0.277083333. PubMed
  156. Lee L, et al. 2016. PLoS One. 11:e0167693. PubMed
  157. Arce-Cerezo A, et al. 2015. Sci Rep. 5: 1448. PubMed
  158. Ballet R, et al. 2014. PLoS Pathog. 10:1004550. PubMed
  159. Choi EW, et al. 2020. Sci Rep. 10:12001. PubMed
  160. Denny JE, et al. 2019. Sci Rep. 2.786111111. PubMed
  161. Liu C et al. 2019. Immunity. 51(2):381-397 . PubMed
  162. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  163. Gao C, et al. 2017. Mol Neurobiol.. 10.1007/s12035-016-0318-0. PubMed
  164. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  165. Wuggenig P, et al. 2020. Commun Biol. 3:130. PubMed
  166. Merrell AJ, et al. 2021. Hepatology. 74:444. PubMed
  167. Chen C, et al. 2021. J Virol. 95:e0082921. PubMed
  168. Yu W, et al. 2022. Nat Commun. 13:3544. PubMed
  169. Scholz F, et al. 2015. J Immunol. 195: 2335-2342. PubMed
  170. Koelwyn GJ, et al. 2020. Nat Med. 1452:26. PubMed
  171. Kim SJ, et al. 2020. Cell Mol Immunol. 17:728. PubMed
  172. Robinett RA et al. 2018. Cell systems. 7(1):41-48 . PubMed
  173. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  174. Mohamed E, et al. 2020. Immunity. 52(4):668-682.e7.. PubMed
  175. Zhang CR, et al. 2022. Blood Cancer Discov. 3:220. PubMed
  176. Takaku S, et al. 2022. Evid Based Complement Alternat Med. 2022:6122955. PubMed
  177. Wang S, et al. 2021. Commun Biol. 22:. PubMed
  178. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  179. Song J, et al. 2021. Am J Physiol Heart Circ Physiol. 320:H323. PubMed
  180. Bent EH, et al. 2021. Nat Commun. 12:6218. PubMed
  181. Nahrendorf W, et al. 2021. eLife. 10:00. PubMed
  182. Mansouri S, et al. 2020. Mucosal Immunol. 0.954861111. PubMed
  183. Sasaki Y, et al. 2015. PLoS One. 10: 0131176. PubMed
  184. Kalafati L, et al. 2020. Cell. 183:771. PubMed
  185. Burgener SS, et al. 2019. Cell Rep. 27:3646. PubMed
  186. Duarte D, et al. 2018. Cell Stem Cell. 22:64. PubMed
  187. Ivan DC, et al. 2021. Front Immunol. 12:666961. PubMed
  188. Franklin DA, et al. 2020. JCI Insight. 5:. PubMed
  189. Omatsu Y, et al. 2022. Nat Commun. 13:2654. PubMed
  190. Liu W, et al. 2022. J Clin Invest. 132: . PubMed
  191. Schönberger K, et al. 2022. STAR Protoc. 3:101408. PubMed
  192. Njock MS, et al. 2022. J Extracell Vesicles. 11:e12228. PubMed
  193. Calderon B, et al. 2015. J Exp Med. 212: 1497-1512. PubMed
  194. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  195. Moro T, et al. 2016. PLoS One. 11: 0146592. PubMed
  196. Kobia FM, et al. 2020. PLoS Biol. 18:e3000850. PubMed
  197. Bordas M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  198. Bellomo A, et al. 2020. Immunity. 53(1):127-142.e7. PubMed
  199. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  200. Onai N, et al. 2020. Int J Mol Sci. :22. PubMed
  201. Celik H, et al. 2018. Cancer Cell. 34:741. PubMed
  202. Alexander Mildner et al. 2017. Immunity. 46(5):849-862 . PubMed
  203. Yousef H, et al. 2019. Nat Med. 25:988. PubMed
  204. Sadhu S, et al. 2021. J Immunol. 207:1812. PubMed
  205. Sun L, et al. 2022. Adv Sci (Weinh). 9:e2104051. PubMed
  206. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  207. Johnson RM, et al. 2021. Front Immunol. 11:614697. PubMed
  208. Kiss M, et al. 2020. Cancer Immunol Res. 9:309. PubMed
  209. Gourvest M, et al. 2021. Leukemia. . PubMed
  210. Bagati A, et al. 2020. Cancer Cell. 39(1):54-67.e9. PubMed
  211. Gicheva N, et al. 2016. Biochem Biophys Res Commun. 479:1-4. PubMed
  212. Beauchamp N, et al. 2010. J Virol. 84:10191. PubMed
  213. Wang Y, et al. 2020. eLife. 9:e57438.. PubMed
  214. Yu L, et al. 2020. Nat Commun. 2.045833333. PubMed
  215. McKenzie MD, et al. 2019. Cell Stem Cell. 25:258. PubMed
  216. Clemente–Casares X, et al. 2017. Immunity. 47:974. PubMed
  217. Contreras NA, et al. 2019. PLoS Pathog. 15:e1007890. PubMed
  218. Cantor DJ et al. 2019. Cell reports. 26(1):108-118 . PubMed
  219. Baratin M, et al. 2017. Immunity. 47:349. PubMed
  220. Coley WD et al. 2018. F1000Research. 2018 Mar 14 [revised 2018 Jan 1] 0.5125. PubMed
  221. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  222. Shi J, et al. 2022. Front Pharmacol. 12:818326. PubMed
  223. McPhee C, et al. 2013. J Immunol. 191:4581. PubMed
  224. Fujimura N, et al. 2016. Sci Rep. 5:11664. PubMed
  225. Tsunekuni K, et al. 2020. J Clin Med. 9:00. PubMed
  226. Huang WC, et al. 2020. Adv Mater. 32:e2005637. PubMed
  227. Shin M, et al. 2020. Cell Chem Biol. 314:27. PubMed
  228. Kaiser S, et al. 2020. Glia. 68:2427. PubMed
  229. Aggio-Bruce R, et al. 2020. Mol Neurobiol. . PubMed
  230. Santopaolo M, et al. 2021. Front Immunol. 609406:12. PubMed
  231. Molgora M, et al. 2020. Cell. 182:886. PubMed
  232. Asada S, et al. 2018. Nat Commun. 9:2733. PubMed
  233. Kong XF, et al. 2018. Nat Immunol. 19:973. PubMed
  234. Rosen DA, et al. 2019. Sci Transl Med. 11:eaau5266. PubMed
  235. Dokoshi T, et al. 2020. Cell Rep. 30:61. PubMed
  236. Van Den Eeckhout B, et al. 2020. NPJ Vaccines. 0.252777778. PubMed
  237. Süß P, et al. 2020. Cell Reports. 30(12):4082-4095. PubMed
  238. Liu G, et al. 2022. Theranostics. 12:2248. PubMed
  239. Fan HH, et al. 2021. Methods Mol Biol. 2276:203. PubMed
  240. Monteiro LB, et al. 2020. MethodsX. 7:100938. PubMed
  241. Rodriguez-Tirado C, et al. 2022. Cancers (Basel). 14:. PubMed
  242. Lau P, et al. 2022. Cell Mol Immunol. :. PubMed
  243. Harding CL, et al. 2020. Front Cell Infect Microbiol. 10:328. PubMed
  244. Chavez JS, et al. 2022. Cells. 11:. PubMed
  245. Boulch M, et al. 2021. Sci Immunol. 6:. PubMed
  246. Gao P, et al. 2020. Front Immunol. 1.636111111. PubMed
  247. Chen S, et al. 2015. Cancer Res . 7: 519-531. PubMed
  248. Groppa E, et al. 2015. EMBO Mol Med. 2015; 7: 1366 - 1384. PubMed
  249. Gharib S, et al. 2014. J Leukoc Biol. 95:9. PubMed
  250. Alfaro M, et al. 2008. Proc Natl Acad Sci U S A. 105:18366. PubMed
  251. Walker JA, et al. 2020. Immunity. 51(1):104-118. PubMed
  252. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  253. Tippimanchai DD, et al. 2018. Oncoimmunology. 7:e1438105. PubMed
  254. Mansouri S, et al. 2021. J Immunol. 206:2233. PubMed
  255. Franklin R, et al. 2022. Nat Commun. 13:2350. PubMed
  256. Gawish R, et al. 2022. Elife. 11:. PubMed
  257. Akhand SS, et al. 2020. Cancer Immunol Res. 8:1542. PubMed
  258. Xu G, et al. 2015. Free Radic Biol Med. 87: 15-25. PubMed
  259. Zhang S, et al. 2016. PLoS Pathog. 12: 1005617. PubMed
  260. Saul S, et al. 2019. J Leukoc Biol. N/A. PubMed
  261. Severe N et al. 2019. Cell Stem Cell. 25(4):570-583 . PubMed
  262. Boguslawski KM, et al. 2020. Sci Adv. 6:eaax7515. PubMed
  263. Wang L, et al. 2020. J Nanobiotechnology. 18:38. PubMed
  264. Cai T, et al. 2022. Front Immunol. 13:1009932. PubMed
  265. Scheyltjens I, et al. 2022. Nat Protoc. 17:2354. PubMed
  266. Zhang Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  267. Wang Y, et al. 2022. Nat Cell Biol. 24:230. PubMed
  268. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  269. Xie Z, et al. 2020. Light Sci Appl. 9:161. PubMed
  270. Zhang B, et al. 2021. Front Neurol. 607370:12. PubMed
  271. Young K, et al. 2021. Cell Stem Cell. . PubMed
  272. Lucas ED, et al. 2020. Cell Reports. 33(2):108258. PubMed
  273. Zysset D, et al. 2016. Nat Commun. 7:13151. PubMed
  274. Huanga J, et al. 2013. J Immunol Methods. 387:254. PubMed
  275. Maas SLN, et al. 2020. J Neuroinflammation. 17:120. PubMed
  276. Qi S, et al. 2020. Theranostics. 10:1814. PubMed
  277. Zheng W, et al. 2019. Cell Rep. 29:1747. PubMed
  278. Lalor R, et al. 2019. Nutrients. 11. PubMed
RRID
AB_312798 (BioLegend Cat. No. 101215)
AB_312799 (BioLegend Cat. No. 101216)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11.30.2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account